Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...
Eikon Therapeutics is planning to become the second biotech to go public in 2026 in another sign the public markets are ...
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is setting the stage for ...